GH1 and multiple endocrine neoplasia type 1: Overall, pituitary involvement can be seen in 30% to 40% of MEN-1 patients, with growth hormone-secreting tumors representing approximately 5% to 25% of cases, as previously reported (1, 3, 7, 8).